12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's pre-market session, several healthcare stocks showed significant movement. Enveric Biosciences (ENVB) led the gainers with an 83.5% increase, while Venus Concept (VERO) experienced the largest drop among the losers, falling 24.2%. Notably, Maravai LifeSciences (MRVI), ModivCare (MODV), and Ardelyx (ARDX) reported their Q4 earnings, influencing their stock movements.
February 23, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Enveric Biosciences shares soared 83.5% to $1.56, with a market cap of $4.2 million.
The significant increase in ENVB's stock price suggests positive investor sentiment, potentially due to speculative trading or recent company developments.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Maravai LifeSciences shares rose 27.78% to $6.53 after reporting Q4 earnings, with a market cap of $863.1 million.
MRVI's stock price increase following its Q4 earnings report suggests the results were favorable and well-received by investors.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Ardelyx stock declined 11.91% to $7.77 following its Q4 earnings, with a market cap of $1.8 billion.
ARDX's stock price drop after its Q4 earnings announcement indicates the results likely disappointed investors.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
ModivCare's stock declined 12.13% to $38.55 after its Q4 earnings report, with a market cap of $546.8 million.
The decrease in MODV's stock price post-earnings suggests the Q4 results did not meet investor expectations.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Venus Concept stock fell 24.2% to $1.41, with a market cap of $7.7 million.
The sharp decline in VERO's stock price indicates negative market sentiment, possibly due to disappointing company news or broader market trends.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90